HIM
BHVN

Hillsdale Investment Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Hillsdale Investment Management’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-48,100
Closed -$5.7M – 639
2022
Q1 		$5.7M Sell
48,100
-1,100
-2% -$130K 0.37% 81
2021
Q4 		$6.78M Buy
49,200
+40,900
+493% +$5.64M 0.45% 54
2021
Q3 		$1.15M Buy
+8,300
New +$1.15M 0.09% 194